Diagnostic accuracy of optical coherence tomography in bladder cancer patients: A systematic review and meta-analysis
A meta-analysis was performed to evaluate the accuracy of optical coherence tomography (OCT) for diagnostic accuracy studies in bladder cancer patients. English language studies reporting the diagnostic accuracy of OCT for bladder cancer were retrieved from the PubMed, EMBASE and Cochrane
Library databases in December 2014. Histopathology was a reference standard. Sensitivities, specificities, positive likelihood ratios and negative likelihood ratios were calculated, and summary receiver operating characteristic curves were drawn to determine the diagnostic accuracy of OCT.
Finally, 9 eligible studies (468 patients) were included in our metaanalysis. The pooled sensitivity, specificity, positive likelihood ratio and negative likelihood ratio of OCT were 0.96 [95% confidence interval (CI): 0.940.98], 0.82 (95% CI: 0.800.85), 6.83 (95% CI: 3.2414.1) and 0.05
(95% CI: 0.020.16), respectively. The summary diagnostic odds ratio was 138.88 (95% CI: 29.63650.89) and the overall area under the curve was 0.9735. These results suggest that OCT has excellent diagnostic performance in patients with bladder cancer and recurrent lesions.
Document Type: Research Article
Affiliations: 1: Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China 2: Department of Obstetrics and Gynecology, Chengdu Integrated TCM and Western Medical Hospital, Chengdu, Sichuan 610041, P.R. China
Publication date: 01 January 2018
- Molecular and Clinical Oncology is a new, bimonthly, peer-reviewed journal, which accepts molecular studies relevant to the mechanisms of disease and all aspects of oncology research, including clinical oncology, chemotherapy, oncogenes, metastasis and viral oncology. The journal provides a home for original research, case reports and review articles.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content